Approval · Notice of Compliance 934 · 2000
APTHERA: Notice of Compliance 934
Issued December 11, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 934
- Date
- December 11, 2000
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Anti-inflammatory, anti-histaminic, leukotriene inhibitor agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APTHERA | 02243118 | Cancelled Pre Market |
Medicinal ingredients
- AMLEXANOX 5 PER